ADXN
Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
ADXN fundamentals
Addex Therapeutics (ADXN) expects to report earnings on Mar 9, 2026, with estimated revenue of 236.62K (YoY --), and EPS at 0 (YoY --).
Revenue estimate / YoY
236.62K
--
EPS estimate / YoY
0
--
Report date
Mar 9, 2026
Earnings
EPS
Revenue
Revenue & Expenses
ADXN has released its 2025 Q3 earnings report, with revenue of 62.26K, reflecting a YoY change of -9.89%, and net profit of -1.98M, showing a YoY change of -9.27%. The Sankey diagram below clearly presents ADXN's revenue sources and cost distribution.
Key Indicators
Addex Therapeutics (ADXN) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Addex Therapeutics (ADXN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Addex Therapeutics (ADXN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Addex Therapeutics (ADXN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Addex Therapeutics (ADXN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Addex Therapeutics (ADXN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Addex Therapeutics's revenue and profit?What is Addex Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Addex Therapeutics year over year?What guidance did Addex Therapeutics's management provide for the next earnings period?Did Addex Therapeutics beat or miss consensus estimates last quarter?What is Addex Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Addex Therapeutics's earnings call?What were the key takeaways from Addex Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
